DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Actonel (Risedronate Sodium) - Current Clinical Trials

 
 



Actonel Related Clinical Trials

A Study of Actonel for the Prevention of Bone Loss [Completed]

Study Comparing Bone Loss in Women Who Take Calcium and Vitamin D With Women Who Also Take Risedronate or Exercise [Recruiting]

Study to Evaluate the Safety and Efficacy of Denosumab and Actonel´┐Ż in Post Menopausal Women Transitioned From Alendronate Therapy [Completed]

A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets [Active, not recruiting]

Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer [Completed]

Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use [Completed]

Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy [Completed]

Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate [Completed]

Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD [Completed]

Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis [Completed]

A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis [Completed]

A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets [Active, not recruiting]

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period [Completed]

Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty [Completed]

Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children [Completed]

A Study of Monthly Risedronate for Osteoporosis [Completed]

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover [Completed]

Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects [Completed]

Bone Loss in Women With Anorexia Nervosa [Completed]

Food Effects on the Relative Bioavailability of Different Dosages of Risedronate [Completed]

Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer [Completed]

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose [Completed]

Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate [Completed]

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis [Completed]

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy [Active, not recruiting]

Effect of Actonel on Periodontal Health of Postmenopausal Women [Recruiting]

Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone [Recruiting]

Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food [Completed]

A Study Comparing Monthly Bonviva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis. [Completed]

Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis [Completed]

A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) [Completed]

Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate [Completed]

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation [Terminated]

Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis [Recruiting]

A Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids [Active, not recruiting]

Risedronate Sodium in Post Menopausal Osteoporosis [Completed]

Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO [Completed]

Satisfaction and Compliance of Risedronate in PMO [Completed]

POWER Point of Care Effect on Satisfaction of Treatment [Completed]

Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate [Completed]

Post-menopausal Women Osteoporosis(Phase III) [Completed]

IGF-1 and Bone Loss in Women With Anorexia Nervosa [Recruiting]

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period [Completed]

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women [Completed]

Risedronate in Osteopenic Postmenopausal Women [Completed]

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis [Completed]

A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects [Completed]

Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease [Completed]

To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women [Recruiting]

SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture. [Completed]

ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week [Terminated]

Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis [Completed]

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women [Completed]

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer [Completed]

Prevention of Osteoporosis in Breast Cancer Survivors [Completed]

36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate Tablets [Active, not recruiting]

VERtebral Fracture Treatment Comparisons in Osteoporotic Women [Active, not recruiting]

Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey) [Recruiting]

Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women [Completed]

Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer [Completed]

Risedronate in Postmenopausal Women With Low Bone Density [Completed]

Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women [Completed]

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women [Completed]

Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women [Completed]

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) [Completed]

Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty [Recruiting]

Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury. [Completed]

Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury [Completed]

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method [Completed]

Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients. [Completed]

The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study) [Completed]

Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy [Completed]

IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment) [Completed]

Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM) [Completed]

Antiepileptic Drugs and Osteoporotic Prevention Trial [Completed]

Bone Microarchitecture in Osteopenic Postmenopausal Women [Terminated]

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture [Active, not recruiting]

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS [Withdrawn]

Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis [Enrolling by invitation]

A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) [Completed]

Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study [Completed]

Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis [Completed]

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density [Terminated]

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy. [Completed]

Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use [Recruiting]

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27 [Completed]

Arimidex Bone Mass Index and Oral Bisphosphonates [Completed]

VERTOS-II. Percutaneous Vertebroplasty Versus Conservative Therapy [Active, not recruiting]

Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy [Completed]

Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients [Completed]

Vitamin K and Bone Turnover in Postmenopausal Women [Completed]

Safety Assessment Among Women With Postmenopausal Osteoporosis and Men With Osteoporosis in Multiple Observational Databases [Recruiting]

Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015